SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-16-000924
Filing Date
2016-12-13
Accepted
2016-12-13 13:54:24
Documents
3
Period of Report
2016-12-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K canabics_8k.htm 8-K 14422
2 RESIGNATION OF MR. WEINBERG canabics_8k-ex9901.htm EX-3.1 3807
3 BOARD OF DIRECTORS RESOLUTION canabics_8k-ex9902.htm EX-99.2 4711
  Complete submission text file 0001683168-16-000924.txt   24385
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52403 | Film No.: 162048477
SIC: 2834 Pharmaceutical Preparations